Macrophages, specialized immune cells in the gallbladder lining, take up excess cholesterol. As cholesterol accumulates within these cells, the affected mucosal area can project from the gallbladder wall. This cellular process explains why the lesions are attached growths rather than freely moving material, helping distinguish them from gallstones during imaging assessment.
Attachment provides an important imaging clue because cholesterol polyps generally remain fixed to the gallbladder wall, whereas gallstones are freely mobile. Clinicians consider this behavior together with size and visual appearance rather than relying on one feature alone. The distinction supports more accurate interpretation of abdominal imaging and helps guide subsequent assessment.
Size, appearance, and change over time are the main features used to identify lesions that may require closer evaluation. Most cholesterol polyps remain benign, but less common neoplastic polyps can carry a higher malignancy risk. A lesion that appears atypical or changes during follow-up may therefore prompt a different management discussion.
Ultrasound surveillance provides repeated assessments of a lesion’s size, appearance, and stability over time. Clinicians use these observations to refine risk assessment rather than treating every detected polyp immediately. Continued stability can support observation, while concerning imaging features or interval change may lead to consideration of gallbladder removal.
Gallbladder removal may be considered when imaging shows features associated with a higher risk of malignancy. Decisions are informed by the polyp’s size, appearance, and behavior during surveillance, not simply by its presence. Because most cholesterol polyps cause no symptoms and remain benign, follow-up is often relevant before an intervention is chosen.
Abdominal imaging can reveal these lesions even when a person has no symptoms. Ultrasound then helps characterize their attachment, size, appearance, and changes over time. That information allows clinicians to distinguish a likely benign cholesterol polyp from a less common neoplastic lesion and to select surveillance or further management according to the assessed risk.